FOLLOWUS
Natural Products Research Laboratory, Higher School of Chemical Engineering and Extractive Industries,Mexico City,Mexico
Published:2018,
Published Online:19 October 2018,
Scan for full text
Rosa, M.P.G., Jose, M.M.F. Petiveria alliacea Suppresses Airway Inflammation and Allergen-Specific Th2 Responses in Ovalbumin-Sensitized Murine Model of Asthma., Chin. J. Integr. Med. 24, 912–919 (2018). https://doi.org/10.1007/s11655-018-2566-5
Martha Perez Gutierrez Rosa, Maria Mota Flores Jose. Petiveria alliacea Suppresses Airway Inflammation and Allergen-Specific Th2 Responses in Ovalbumin-Sensitized Murine Model of Asthma. [J]. Chinese Journal of Integrative Medicine 24(12):912-919(2018)
Rosa, M.P.G., Jose, M.M.F. Petiveria alliacea Suppresses Airway Inflammation and Allergen-Specific Th2 Responses in Ovalbumin-Sensitized Murine Model of Asthma., Chin. J. Integr. Med. 24, 912–919 (2018). https://doi.org/10.1007/s11655-018-2566-5 DOI:
Martha Perez Gutierrez Rosa, Maria Mota Flores Jose. Petiveria alliacea Suppresses Airway Inflammation and Allergen-Specific Th2 Responses in Ovalbumin-Sensitized Murine Model of Asthma. [J]. Chinese Journal of Integrative Medicine 24(12):912-919(2018) DOI: 10.1007/s11655-018-2566-5.
To examine the effect of metanol extract of Petiveria alliacea (PM) on airway inflflammation in a murine model of chronic asthma. Two-month-old male BALB/c mice (n=6–8/group) were sensitized on days 0 and 14 by intraperitoneal injection of 20 μg ovalbumin (OVA). On day 25
the mice received an airway challenge with OVA (3%
w/v
in phosphate buffered saline). PM was administered orally by oral gavage to mice at doses of 100
200 and 400 mg/kg body weight once daily from days 18 to 23. Control mice were orally administered phosphate buffered saline (PBS) to induce a model of asthma. At the end of the test
respiratory reactivity was assayed
the total cell number
interleukin-4 (IL-4)
IL-5
IL-13
tumor necrosis factor-alpha (TNF-α) and reactive oxygen species (ROS) in the bronchoalveolar lavage fluid (BALF) were determined and the levels of serum IgE
intercellular cell adhesion molecule 1 (ICAM-1) and eotoxin were measured. In addition
lung tissue was used to qualify the IL-4
IL-5
IL-13
TNF-α and transforming growth factor beta 1 (TGF-β1). Histologic examination was performed to observe inflammatory cellular infiltration. The administration of PM in comparison with the OVA-only treated group signifificantly attenuated the infifiltration of eosinophils and other inflflammatory cells (P<0.01). Airway resistance (RI) in the OVA-only induced group was significantly higher than that of the PBS control group (P<0.01) when methacholine was added. TNF-α
IgE
TGF-β1 and cytokine levels IL-4
IL-5
IL-13 in the BALF decreased compared to control mice (P<0.01 or P<0.05). PM treatment also inhibited the production of chemokines
eotaxin and ICAM-1 in BALF (P<0.01)
which improved lung function. Histopathological examination revealed that the sensitized treated PM groups had significant lower in inflammatory scores similar to dexamethasone treatments and the untreated group. Administration of PM could inhibit airway inflammation
regulate cytokines
chemokines and enhance pulmonary conditions in allergic murine model of asthma.
To examine the effect of metanol extract of Petiveria alliacea (PM) on airway inflflammation in a murine model of chronic asthma. Two-month-old male BALB/c mice (n=6–8/group) were sensitized on days 0 and 14 by intraperitoneal injection of 20 μg ovalbumin (OVA). On day 25
the mice received an airway challenge with OVA (3%
w/v
in phosphate buffered saline). PM was administered orally by oral gavage to mice at doses of 100
200 and 400 mg/kg body weight once daily from days 18 to 23. Control mice were orally administered phosphate buffered saline (PBS) to induce a model of asthma. At the end of the test
respiratory reactivity was assayed
the total cell number
interleukin-4 (IL-4)
IL-5
IL-13
tumor necrosis factor-alpha (TNF-α) and reactive oxygen species (ROS) in the bronchoalveolar lavage fluid (BALF) were determined and the levels of serum IgE
intercellular cell adhesion molecule 1 (ICAM-1) and eotoxin were measured. In addition
lung tissue was used to qualify the IL-4
IL-5
IL-13
TNF-α and transforming growth factor beta 1 (TGF-β1). Histologic examination was performed to observe inflammatory cellular infiltration. The administration of PM in comparison with the OVA-only treated group signifificantly attenuated the infifiltration of eosinophils and other inflflammatory cells (P<0.01). Airway resistance (RI) in the OVA-only induced group was significantly higher than that of the PBS control group (P<0.01) when methacholine was added. TNF-α
IgE
TGF-β1 and cytokine levels IL-4
IL-5
IL-13 in the BALF decreased compared to control mice (P<0.01 or P<0.05). PM treatment also inhibited the production of chemokines
eotaxin and ICAM-1 in BALF (P<0.01)
which improved lung function. Histopathological examination revealed that the sensitized treated PM groups had significant lower in inflammatory scores similar to dexamethasone treatments and the untreated group. Administration of PM could inhibit airway inflammation
regulate cytokines
chemokines and enhance pulmonary conditions in allergic murine model of asthma.
Petiveria alliaceaallergyantiinflflammationAsthma
Petiveria alliaceaallergyantiinflflammationAsthma
Berend N, Salome CM, King GG. Mechanisms of airway hyperresponsivess in asthma. Respirology 2008;13:624–631.
Torres R, Herrerias A, Serra-Pages M, Marco A, Plaza J, Costa-Farre C, et al. Locally administered prostaglandin E2 prevents aeroallergen-induced airway sensitization in mice through immunomodulatory mechanisms. Pharmacol Res 2013;70:50–59.
Deng Y, Guan M, Xie YX, Xiang H, Li H. Geniposide inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. Int Immunopharmacol 2013;17:561–567.
Chung MJ, Sohng JK, Choi DJ, Park YI. Inhibitory effect of phloretin and biochanin A on IgE-mediated allergic responses in rat basophilic leukemia RBL-2H3 cells. Life Sci 2013;93:401–408.
Kima S, Kubec R, Rabi A. Musaha Antibacterial and antifungal activity of sulfur-containing compounds from Petiveria alliacea L. J Ethnopharmacol 2006;104:188–192.
Kubec R, Musah RA. Cysteine sulfoxide derivatives in Petiveria alliacea. Phytochemistry 2001;58:981–985.
Kubec R, Kim S, Musah RA. S-Substituted cysteine derivatives and thiosulfinate formation in Petiveria alliacea—part II. Phytochemistry 2002;61:675–680.
Kubec R, Kim S, Musah RA. γ-Glutamyl dipeptides in Petiveria alliacea Musah. Phytochemistry 2005;66:2494–2497.
Benevidesa PJC, Young MCM, Giesbrechta AM, Roquea NF, Vanderlan S. Antifungal polysulphides from Petiveria alliacea L. Phytochemistry 2001;57:743–747.
Lopes-Martins RAB, Pegoraro DH, Woisky R, Penna SC, Sertié JAA. The anti-Inflammatory and analgesic effects of a crude extract of Petiveria alliacea L. (Phytolaccaceae). Phytomedicine 2002;9:245–248.
Chen ML, Lin BF. Effects of triterpenoid-rich extracts of Ganoderma tsugae on airway hyperreactivity and Th2 responses in vivo. Intern Archives Allergy Immun 2007;143:21–30.
Nials AT, Uddin S. Mouse models of allergic asthma: acute and chronicallergen challenge. Dis Model Mech 2008;1:213–220.
Altman LV, Ayars GH, Baker C, Luchtel DL. Cytokines and eosinophil-derived cationic proteins upregulate intercellular cell adhesionmolecule-1 on human nasal epithelial cells. J Allergy Clin Immunol 1993;92:527–536.
Xinxin C, Chi C, Xiao C, Xue X, Yongjun Y, Junqing C: Florfenicol inhibits allergic airway inflammation in mice by p38 MAPK-mediated phosphorylation of GATA 3. Clin Immunol 2011;138:231–238.
Chen ML, Lin BF. Effects of triterpenoid-rich extracts of Ganoderma tsugae on airway hyperreactivity and Th2 responses in vivo. Intern Archives Allergy Immun 2007;143:21–30.
Bao Z, Guan S, Cheng C, Wu S, Wong SH, Kemeny DM. A novel ntiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am J Respir Crit Care Med 2009;179:657–665.
Mee MY, Seo CS, Lee JA, Lee NM, Ha HK. Anti-asthmatic effect of Angelica dahurica against ovalbumin-induced airway inflammation via upregulation of heme oxigenase. J Food Toxicol 2011;49:829–837.
Okada Y, Tanaka K, Sato E, Okajima T. Antioxidant activity of the new thiosulfinate derivative s-benzyl phenylmethanethiosulfinate from Petiveria alliacea L. Org Biomol Chem 2008;6:1097–1102.
Moreno-Macias H, Romieu I. Effects of antioxidant supplements and nutrients on patients with asthma and allergies. J Allergy Clin Immunol 2014;133:1237–1244.
Lloyd CM, Saglani ST. Cells in asthma: influences of genetics, environment, and T-cell plasticity. J Allergy Clin Immunol 2013;131:1267–1274.
Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008;454:445–454.
Gong JH, Shin DK, Han SY, Kim JL, Kang YH. Kaempferol suppress eosinophil infiltration and airway inflammation in airway epithelial cells and in mice with allergic asthma. J Nutr 2012;142:47–56.
Radinger M, Lotval l J. Eosinophi l progeni tors in allergy and asthma—do they matter? Pharmacol Ther 2009;121:174–184.
Al-Muhsen S, Vazquez-Tello A, Alzaabi A, Al-Hajjaj MS, Al-Jahdali HH, Halwani R. IL-4 receptor alpha singlenucleotide polymorphisms rs1805010 and rs1801275 are associated with increased risk of asthma in a Saudi Arabian population. Annals Thoracic Med 2014;9:81–86.
Kouro T, Takatsu K. IL-5-and eosinophil-mediated inflammation: from discovery to therapy. Intern Immunol 2009;21:1303–1309.
MacKenzie JR, Mattes J, Dent LA, Foster PS. Eosinophils promote allergic disease of the lung by regulating CD4+ Th2 lymphocyte function. J Immunol 2001;167:3146–3155.
Provost V, Langlois A, Chouinard F. Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells. PLoS ONE 2012;7:e43544.
Chung MJ, Park JW, Park YI. Anti-inflammatory effects of low-molecular weight chitosan oligosaccharides in IgEantigen complex-stimulated RBL-2H3 cells and asthma model mice. Int Immunopharmacol 2012;12:453–459.
Scherf W, Burdach S, Hansen G. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model. Eur J Inmmunol 2005;35:198–206.
0
Views
0
Downloads
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution